Viatris Inc. (NASDAQ: VTRS)
Viatris Inc. (NASDAQ: VTRS) is a pharmaceutical company that provides medicines and long-term therapy to patients in more than 165 countries. Its portfolio is diversified into Brands, Complex Generics and Biosimilars, and Generic divisions, contains approximately 1,400 authorized compounds across a variety of therapeutic areas that tackle both communicable and non-communicable disorders.
Disclaimer-
This report (“Report”) has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and…
